Generex Biotechnology Corporation Appoints Mark J. Prioletti to the Board of Directors
08. April 2019 09:00 ET
|
Generex Biotechnology Corp.
Sales & Marketing Executive Brings Global Expertise in Global Channel Marketing MIRAMAR, FL, April 08, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Generex Biotechnology...
Generex Biotechnology Announces the Appointment of Chief Commercial Officer
12. März 2019 09:00 ET
|
Generex Biotechnology Corp.
Lance Goudzwaard Appointed to Head Commercialization and Customer Relations for NuGenerex Distribution Solutions Subsidiary MIRAMAR, FL, March 12, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE –...
Generex Investor Conference Call Now Available Online
01. März 2019 09:00 ET
|
Generex Biotechnology Corp.
MIRAMAR, FL, March 01, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Generex Biotechnology Corporation (www.generex.com) (OTCQB: GNBT) (http://www.otcmarkets.com/stock/GNBT/quote) today announced the...
Reminder: Investor Conference Call Today, February 26, 2019; Management to Provide Update on Initiatives & Strategic Plans, Call-in Details
26. Februar 2019 08:00 ET
|
Generex Biotechnology Corp.
MIRAMAR, FL, Feb. 26, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Generex Biotechnology Corporation (www.generex.com) (OTCQB: GNBT) (http://www.otcmarkets.com/stock/GNBT/quote) today announced the...
Generex Biotechnology Announces Investor Conference Call Agenda; Tuesday, February 26, at 11:00 A.M. Eastern
15. Februar 2019 09:00 ET
|
Generex Biotechnology Corp.
Management to Provide Update on Strategic Acquisitions, Financing, Growth Initiatives & Spin Out of NuGenerex Immuno-Oncology MIRAMAR, FL, Feb. 15, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE...
Generex Biotechnology Announces Investor Conference Call Scheduled for February 26, 2019
29. Januar 2019 09:00 ET
|
Generex Biotechnology Corp.
Management to Provide Details on NuGenerex Immuno-Oncology: Dividend, New Acquisitions, IP Licensing Opportunities, and Strategic Plans for Public Listing Acquisition, Integration of Fuse...
Generex Announces Investor Conference Call-in Details; Management to Provide Update on Initiatives & Strategic Plans
14. Januar 2019 09:00 ET
|
Generex Biotechnology Corp.
MIRAMAR, FL, Jan. 14, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Generex Biotechnology Corporation (www.generex.com) (OTCQB: GNBT) (http://www.otcmarkets.com/stock/GNBT/quote), today announced the...